KATHERINE MUNIZ: Open Payments
NPI 1073077608 · GLENVIEW, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 46 payments from 6 companies in 2025. Trend: 2023 $513 · 2024 $667 · 2025 $1,453
Food & beverage: $1,085Travel & lodging: $368
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 7 | $467 |
| Novartis Pharmaceuticals Corporation | 16 | $432 |
| Abbott Laboratories | 9 | $259 |
| E.R. Squibb & Sons, L.L.C. | 11 | $197 |
| AstraZeneca Pharmaceuticals LP | 2 | $62 |
| BridgeBio Pharma, Inc. | 1 | $37 |
Products named: Barostim Neo System, LEQVIO, CARDIOMEMS, CAMZYOS, WAINUA, Attruby, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, ELIQUIS.
Industry payments across IL — which companies pay providers there.
